NLRP3 and Alzheimer disease: In AD, the NF-κB pathway and expression of the NLRP3 block the phagocytosis of Aβ fibrils, which results in increasing the buildup of Aβ fibrils in the brain, creating a self-perpetuating loop and finally leads to neuroinflammation [114].